Monthly Archives: July 2020

By Nella Letizia, WSU Libraries

In 1942, Londons Hogarth Press published a pamphlet by British physician Isaac Harris called The Calcium Bread Scandal, a spirited denunciation of the Food Ministrys proposal of adding nutrients, including calcium, to bread as a way to fortify the health of the British public during wartime.

In any case, the disease [osteoporosis] is so rare that adding calcium to bread for this purpose [preventing osteoporosis] would be like burning a house in order to roast a pig, the good doctor wrote.

WSUs Manuscripts, Archives and Special Collections (MASC) recently acquired Harriss colorful and rare pamphlet, thanks to a $10,000 bequest of former MASC employee Leila Luedeking, who supported the Hogarth Press Collection as well as the Leonard and Virginia Woolf Library during her life.

While working at MASC from 1973 to 1998, Luedeking cataloged many of its rare book collections and especially contributed to the description of the Woolf Library. She served as a crucial resource for Woolf scholars in the United States and the United Kingdom who corresponded with the department. MASCs files include detailed letters and emails that Luedeking wrote to them.

She was a recognized expert on the work of Leonard Woolf and coauthored an important bibliography of his vast literary, political and critical publications, said Trevor Bond, WSU Libraries associate dean of digital initiatives and special collections. This work remains the standard source for Leonard Woolf.

With the acquisition of The Calcium Bread Scandal, MASC reached its goal of holding a copy of every title published by Hogarth Press from its founding by Virginia and Leonard Woolf in 1917 until Leonard sold his interest in the press in 1946, said special collections librarian Greg Matthews.

Harriss pamphlet has two parts: The first is his main diatribe against the Food Ministrys plan, which he explains in 10 points. The second reprints four letters Harris submitted to the editors of newspapers and medical journals arguing against the medical efficacy of adding nutritional supplements to bread. These pieces are more technical.

Harris objected to the Food Ministrys proposal for other reasons than the rarity of osteoporosis in the population. He also pointed out that Vitamin D aids the physiological absorption of calcium, so adding the mineral supplement without its necessary vitamin counterpart would be ineffective. Finally, Harris viewed the bread supplement scheme as a symptom of the very fascism the Allies were fighting against, Matthews said.

To-day it is one food crank who becomes the dictator; to-morrow there may be another, Harris wrote. To-day it is calcium; to-morrow, Heaven knows what else may be imposed upon us.

Matthews appreciates the doctors candor. Harriss writing style was clear as befits an expert writing for a general audience, though he exhibited a flair for simile and rousing rhetoric, encouraging his readers to resist the rise of tyranny at home, he said.

Luedeking came to Pullman in 1956 when her husband, Robert, was hired by WSU to teach chemical engineering. The couple raised five daughters here, and according to her obituary, Luedeking joined her husband at the university first as a graduate student and then as an employee in MASC when her youngest started preschool.

Colleagues who worked with Luedeking found her to be a good bibliographer. Rare books cataloger Julie King, who started working in MASC in 1986, remembers that Luedeking was involved at the start when MASC obtained the Woolf Library in the early 1970s.

Leila catalogued the bulk of the Woolf Library, King said. She was quite protective of the books, and rightly so. At the time, the Woolf Library was interfiled with the other books in MASC, and we have since collected it all into its own section in the book stacks, but Leila provided the foundation work.

Luedeking also initiated getting many MASC collections catalogued online, including those associated with Leonard and Virginia Woolf.

We were members of the Washington Library Network at the time, and Leila got us on the online format, King said. She and humanities librarian Ann Wierum were responsible for acquiring many of our English literature sub-collections: D.H. Lawrence, John Masefield, Vita Sackville-West, Henry James and others.

I could tell she was fussy about details, she added. I am, toothats what makes a good cataloguer, so I made sure to have everything just so.

Luedekings devotion to the Woolf collections didnt stop with her retirement in 1998; Bond said she regularly gave to MASC afterward until her death last November so that the department could continue to collect items.

I had the pleasure of working with Leila for a few months before she retired, he said. I remembered her as a quiet, sharp and dedicated colleague.

See the article here:

Rare pamphlet added to MASC Hogarth Press collection with employee bequest - WSU News

The awards cover 14 categories, including products of the year. These awards showcase the best in finished product innovations and market successes in specific categories, including omega-3, probiotic and sports nutrition.

The product of the year for Omega-3 recognizes the best branded or own-label supplements, foods and beverages containing omega-3 as a core ingredient.

Winner: Omega-3 with Xtra Absorb by Nature Made

Nature Made Omega-3 with Xtra Absorb technology is made with a specially designed emulsion system to enable nearly 4x better absorption than standard fish oil concentrate.

The judges viewed the smaller pills that can achieve therapeutic blood levels as somewhat of a game changer. This technology, coupled with impressive sales data, made for a winning product.

We are thrilled to have Nature Mades Omega-3 with Xtra Absorb named NutraIngredients Omega-3 Product of the year, commented Tobe Cohen, EVP, Chief Growth Officer at Pharmavite LLC, makers of Nature Made brand vitamins.This honor is a reflection of our deep commitment to delivering high-quality products rooted in science, a mission that is more important now than ever as Americans look for trusted and proven vitamins and supplements to bolster their health and wellness.

The Probiotic Product of the Year award celebrates the best branded or own-label supplements, functional foods and beverages containing probiotics. Interest in probiotics and the potential benefits of a healthy microbiome have led to multiple years of stellar growth for probiotic products.

Winner: Baby's Nordic Flora Probiotic Powder by Nordic Naturals

Babys Nordic Flora Probiotic Powder delivers digestive support for little ones 6-months to 3 years old and combines two extensively studied probiotic strainsLactobacillus rhamnosus GG and Bifidobacterium animalis ssp. Lactis.

The judges called this a well-thought out product for a clearly-defined and under-served category with two strains that are supported by solid science.

What great news! enthused Nick Noloboff, Senior Writer, Nordic Naturals. Winning Product of the Year for our Babys Probiotic Powder is especially meaningful to us given the work that Nordic Naturals has done to expand our supplement line and maintain the product quality that customers rely on. Ever since we introduced a higher standard of fish oil 25 years ago, innovation has been our thing. Weve always believed that with the right approach to ingredients and manufacturingand by always prioritizing qualitythe opportunity to innovate and excel is endless. Thanks for recognizing our commitment to making better supplements.

The Sports Nutrition Product of the Year is a new award for 2020, and it was as competitive as you might expect from such a category. Sports and active nutrition products are positioned for both niche athletic populations and the more mainstream active consumer.

This award celebrates the best branded or own-label supplements, functional foods and beverages positioned to enhance athletic performance and recovery.

Winner: 2before blackcurrant powder by 2before Performance Nutrition

2before is a berry juice powder providing a proven, efficacious dose of polyphenols from Adaptive New Zealand blackcurrants to deliver a significant sports performance improvement.

The judges appreciated the evidence behind this product, its clean sourcing story as well as its third-party lab certification.

Brendan Vercoe, Commercial Development Manager, Plant, New Zealand Institute for Plant and Food Research, toldNutraIngredients-USA that the award is an honor:Adaptive blackcurrants are a known elite sports nutrition ingredient in New Zealand, but we wanted to create a finished product that would resonate in the US market. So we set out to create a food first performance brand in a format that would allow athletes to create a new pre-ritual. We are extremely honored for NutraIngredients-USA to validate all the hard work we have put into both world-class research, but also ultimately a product that we hope can make a significant difference to athletic performance, recovery and immunity, as we count down a year to the Tokyo Olympics. We will continue to educate dietitians and athletes on the benefits of Adaptive New Zealand blackcurrants and seek to create a category for food first performance nutrition.

See original here:

2020 NutraIngredients-USA Product of the Year Winners - NutraIngredients-usa.com

1. Introduction

Commentary on EU life science advertising regulation frequentlyfocuses on the rules applicable to advertisements for prescriptionproducts directed to healthcare professionals. Less iswritten about other types of products that form part of the EUhealthcare market, and the advertising restrictions that exist inrelation to the marketing of these products to consumers.While advertising restrictions on over-the-counter (OTC) productsare not, generally speaking, as detailed and stringent as thosewhich exist in relation to prescription medicines, it isnevertheless important to be aware of the regulatory framework thatapplies to consumer advertisements for such products. Thischapter is, therefore, intended to provide a summary of theoverarching EU regulatory framework for consumer advertisingof:

The European market for these OTC consumer healthcare productsis made up of over 2,000 companies.1 We summarisehere the general framework of law and industry codes of practicethat exist at EU level to regulate the advertising of thesecategories of products to consumers, with examples from nationalapproaches and commenting, where relevant, on recent developments.

At EU level, Directive 2005/29/EC on unfair commercialpractices2 (the UCP Directive) governsbusiness-to-consumer commercial practices relating to all kinds ofproducts and services including medicines, medical devices andfoods. In particular, the UCP Directive contains a broadprohibition on misleading and aggressive advertising. Forthese purposes, advertising is misleading if it contains falseinformation or in any way (including through overall presentation)deceives or is likely to deceive the average consumer (even if theinformation is factually correct) and causes or is likely to causehim to take a transactional decision that he would have otherwisenot taken. Aggressive commercial practices includeadvertising that applies undue influence, or pressure, in a waywhich significantly limits the consumer's ability to make aninformed decision. There are also restrictions on comparativeadvertising set out in Directive 2006/114/EC3 whichapply to advertising directed at consumers. The EU lawprovisions, as implemented in national laws, are enforcednationally through varying mechanisms; in some Member States it ispossible for companies to bring direct actions against competitors,whereas other countries require actions to be brought only byregulatory authorities. National laws may contain additionalrestrictions on both general and product-specific consumeradvertising.

Several pan-European industry bodies represent the interests ofmanufacturers of consumer healthcare products. These includethe Association of the European Self-Care Industry (AESGP), whichrepresents manufacturers of non-prescription medicines, foodsupplements and self-care medical devices in Europe, and theEuropean Federation of Associations of Health Product Manufacturers(EHPM), which represents specialist health product manufacturers inEurope. Individual companies may be affiliated with theseEuropean bodies directly or indirectly through nationalassociations. For example, the Dutch association representingmanufacturers of self-care products (Neprofarm) is a member ofAESGP while its trade association for operators concerned with foodsupplements (NPN) is a member of EHPM. Some national industrybodies are charged with operating self-regulatory systems ofadvertising control, and have their own enforcement mechanisms inplace. For example, in the UK, advertisements issued bycompanies who are members of the Proprietary Association of GreatBritain (PAGB) will, in the first instance, be supervised by thePAGB, whereas companies which have not agreed to abide by thePAGB's Codes of Practice will be supervised directly by theMedicines and Healthcare products Regulatory Agency. Inaddition to sector-specific enforcement agencies, advertising andpromotion of consumer health products is also subject toenforcement by bodies who enforce advertising standards generally,such as the UK Advertising Standards Agency (ASA).

The advertising to consumers of medicines not subject toprescription is regulated by the general advertising rules outlinedabove, and by Directive 2001/83/EC (the Directive) as implementedinto national laws. In addition, guidance is sometimesavailable at a national level from regulatoryauthorities,4 independent advertisingbodies,5 and industry associations.6There does not currently exist any pan-European industry code ofconduct applicable to the advertising of non-prescriptionmedicines,7 although AESGP represents the interests ofmanufacturers of non-prescription medicines at European level.

While advertising to the general public of prescription-onlymedicines is prohibited under the Directive, there is no suchrestriction in relation to non-prescription medicines.Provided they have a valid marketing authorisation and do notcontain any narcotic or psychotropic substances, non-prescriptionmedicines (including non-prescription herbal medicines) may,therefore, be advertised both to healthcare professionals and thegeneral public if they comply with the advertising requirements setout in the Directive, and with any further requirements containedin national law (discussed below). In addition to complyingwith the Directive's advertising rules applicable toprescription medicinal products, advertisements of non-prescriptionmedicines to the general public must also:

Advertisements for herbal medicinal products authorised by atraditional herbal registration must be accompanied by a noticestating "traditional herbal medicine for use in specificindication(s) exclusively based on long-standing use".

Homeopathic medicinal products must comply with the general EUlaw advertising requirements applicable to non-prescriptionmedicines, subject to additional limitations on the informationthat may be included in such advertisements. For example,advertisements for homeopathic medicines must include a statementthat the products are "without approved therapeuticindications".

Further restrictions on non-prescription medicines advertisingto consumers may be set out under national law and/or industrycodes. For example, French law prohibits advertising ofnon-prescription medicines to the general public where themedicines are reimbursed under the national social securityschemes. National industry codes of practice frequently setout detailed requirements specific to consumer advertising ofnon-prescription medicines. While compliance with such codesis not legally mandated, it is encouraged and represents industrybest practice. Compliance with the codes, which typicallyreflect and often elaborate on the legal requirements, is usually agood indication of compliance with legal requirements and thereforehelps to minimise enforcement action.

In some European countries, there is a requirement to obtainpre-approval from a regulatory body (e.g., the ANSM in France) oran industry body (e.g., the PAGB in the UK, where membercompanies' advertisements to consumers are concerned) beforeadvertisements for non-prescription medicines may be issued.Obtaining such approval further reduces the risk of enforcementaction for improper advertising.

There is little by way of EU law specifically directed towardsmedical devices advertising. Under the Medical DeviceDirective, only products that are CE-marked may be marketed inEurope, and only in accordance with their intended use. Theseprinciples extend to claims made in advertisements: to make amedicinal claim in an advertisement for a self-care medical device,the device must be CE-marked and the claim must be within the scopeof the device's intended use. Enforcement actions takenat national level in relation to self-care medical devices oftenconcern advertising that has made unauthorised use of medicinalclaims.

The Medical Devices Regulation8 introduces a specificprohibition on advertising that may mislead in relation to adevice's intended purpose, safety and performance.

The position under national laws is patchy, with some countrieshaving introduced laws to further regulate medical deviceadvertising (including, in some cases, laws that specificallygovern the advertising of self-care medical devices) beyond that ofthe EU-wide legislation.

In the context of industry self-regulation, it is important tonote that the Code of Ethical Business Practice issued by theEuropean medical device industry representative body, MedTechEurope, does not govern advertisements directed to consumers.However, several countries have issued national codes of conduct tothis effect; for example, the UK's PAGB Medical DevicesConsumer Code which is applicable to member companies'advertisements concerning self-care medical devices (those thattreat or prevent a self-treatable condition).

Food supplements are regulated as foods under EU law.Regulation (EC) No 1924/20069 (the Claims Regulation),which is directly effective in Member States, places strictcontrols on the use of nutrition and health claims on foodlabelling and in advertising. Under the ClaimsRegulation:

Under the Claims Regulation, only nutrition claims that arelisted in the Annex to the Regulation, and/or health claims thathave been authorised by the European Commission following aEuropean Food Safety Authority scientific review arepermitted. The only exception to these requirements is inrelation to claims that are trade marks (or brand or"fancy" names) and general, non-specific health claims(e.g., "good for you"). These claims may be usedwithout prior approval, provided they are "accompaniedby" an approved claim (which, in the case of a general healthclaim, must be an authorised specific health claim, such as thecalcium example given above).

The Claims Regulation is enforced at national level, andnational regulators have to date taken varying approaches in theirinterpretation of its requirements. A recent decision by theEuropean Court of Justice Case C-524/18Schwabe,10 which followed a referral from aGerman court, has helpfully clarified the meaning of the ClaimsRegulation's use of the phrase "accompaniedby". The European Court held that the concept of"accompanying" includes both a substantive and a visualdimension. The substantive element requires that the contentof the "general" health claim and the specific healthclaim match, meaning that the former is fully supported insubstance by the latter. In relation to the visual element,the Court held that this normally requires "spatial proximityor immediate vicinity" but that, exceptionally, a clearreference, such as an asterisk, between the two claims may suffice(e.g., in cases where the packaging of a food supplement contains areference to general, non-specific health benefits of a nutrient orfood on the front of the packaging, whereas the specific healthclaim intended to accompany it appears only on the back of thatpackaging). This is a more restrictive approach than thatwhich was preferred by the Advocate General,11 but willnevertheless help to inform a more uniform application of therelevant rules across Europe.

Also of importance to food supplements advertising in the EU isDirective 2002/46/EC (the Food Supplements Directive), whichprovides for specific marketing requirements relating to foodsupplements. These include that the labelling, presentationand advertising of food supplements:

There has been a recent flurry of activity by nationalregulators in some European countries in response to advertisementsfor food supplements that purport to prevent or treat infectionwith coronavirus/COVID-19. Such advertisements are contraryto the prohibition on medical claims contained in the FoodSupplements Directive, as implemented in national laws. Forexample, the Finnish Food Authority issued a statement in April2020, noting that marketing of foods (including food supplements)for the purpose of preventing or treating coronavirus had increasedsignificantly on the internet and social media, that these mustimmediately cease, and reminding commercial entities of their legalduties in this regard.13 In the UK, the ASA hasissued several recent decisions which uphold complaints made inrelation to advertisements claiming that various marketed vitamins,minerals and amino acids could help prevent or treatCOVID-19. For example, statements such as "Help protectand prevent against the new strand of virus (known as theCoronavirus) with a REVIV Megaboost IV Therapy containing ahigh dose of Vitamin C" were determined to be contrary to theapplicable regulatory requirements and the advertiser was orderedto remove the material, and refrain from making unauthorisedmedicinal claims going forward.14

Footnotes

1. (Hyperlink) [Accessed 20 May 2020].

2. Directive 2005/29/EC of the European Parliament and ofthe Council of 11 May 2005 concerning unfair business-to-consumercommercial practices in the internal market and amending CouncilDirective 84/450/EEC, Directives 97/7/EC, 98/27/EC and 2002/65/ECof the European Parliament and of the Council and Regulation (EC)No 2006/2004 of the European Parliament and of theCouncil.

3. Directive 2006/114/EC of the European Parliament andof the Council of 12 December 2006 concerning misleading andcomparative advertising.

4. For example, the UK Medicines and Healthcare productsRegulatory Agency (MHRA) "Blue Guide".

5. For example, the UK Advertising Codes applied by theAdvertising Standards Authority (ASA).

6. For example, the UK PAGB's Advertising Codes forMedicines.

7. The European Federation of Pharmaceutical Industriesand Associations (EFPIA) Code of Practice does not apply toactivities relating solely to non-prescriptionmedicines.

8. Article 7 of Regulation (EU) No 2017/745 of theEuropean Parliament and of the Council of 5 April 2017 on medicaldevices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002and Regulation (EC) No 1223/2009 and repealing Council Directives90/385/EEC and 93/42/EEC.

9. Regulation (EC) No 1924/2006 of the EuropeanParliament and of the Council of 20 December 2006 on nutrition andhealth claims made on foods.

10. Case C-524/18, Dr. Willmar Schwabe GmbH &Co.KG v Queisser Pharma GmbH & Co. KG (30 January2020).

11. Opinion of Advocate General Hogan delivered on 12September 2019.

12. Articles 6(2) and 7 of Directive 2002/46/EC of theEuropean Parliament and of the Council of 10 June 2002 on theapproximation of the laws of the Member States relating to foodsupplements.

13. (Hyperlink) [Accessed 20 May2020].

14. ASA Ruling on REVIV UK Ltd (22 April 2020).Similar decisions were issued by ASA on the same day in relation toadvertisements by the Private Harley Street Clinic and CosmeticMedical Advice UK Ltd t/a Dr Rita Rakus Clinic.

Originally published by ICLG.com.

The content of this article is intended to provide a generalguide to the subject matter. Specialist advice should be soughtabout your specific circumstances.

Here is the original post:

An Overview Of EU Rules On Consumer Advertising Of Over-The-Counter Products In The Life Sciences Sector - Media, Telecoms, IT, Entertainment -...

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Protein Supplements market.

Trusted Business Insights presents an updated and Latest Study on Protein Supplements Market 2019-2026. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Protein Supplements market during the forecast period (2019-2029).It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Protein Supplements Market Size, Share, Global Market Research and Industry Forecast Report, 2027 (Includes Business Impact of COVID-19)

Industry Insights, Market Size, CAGR, High-Level Analysis: Protein Supplements Market

The global protein supplements market size was estimated at USD 17.55 billion in 2019, and is expected to expand at a CAGR of 8.0 % during the forecast period, driven by increase in health and fitness centers and consumer health consciousness. Increasing popularity among millennials along with development of innovative protein-based supplements in different forms, coupled with numerous health benefits of the product are some of the major factors driving the growth. Furthermore,positive outlook toward sports nutrition on account of increasing importance of active lifestyle along with rising awareness regarding health benefits of protein is expected to play a crucial role in promoting the use of the supplements.Factors, such as hectic lifestyle and rising health consciousness are anticipated to boost the overall market growth. In addition, growing functional advantages including muscle repair, energy boost, and weight loss are projected to further fuel the demand. Rising usage of snack-based meal replacements and demand for greater ingredient traceability and authenticity are other factors likely to augment the demand for protein supplements in near future.

Various socio-economic factors, including rising disposable income, urbanization, and aging population, are anticipated to positively impact the product demand. In addition, growing concerns regarding obesity, preference for vegan protein sources due to rising veganism, along with rising spending on health-related products is projected to fuel the product demand in near future. Rising penetration of organized retail and e-retailing is expected to further boost the demand in the forthcoming years.A significant rise in gym subscriptions, especially in Asia Pacific along with rising awareness regarding health and fitness among millennials, primarily backed by their robust disposable income is anticipated to further drive the demand for protein supplements. Along with physical activity, millennials prefer including protein powder in the diet. This trend is expected to positively influence the market growth over the forecast period. Rising consumption of packaged nutritional food products such as protein bars and Ready to Drink (RTD) products. Introduction of healthy products by various manufacturers is anticipated to further drive the growth of the market.

Product Insights of Protein Supplements Market

The protein powder segment held around 64.0% of the protein supplements market in terms of revenue in 2019. Factors such as the strong online sales, mass distribution channels, and increasing number of standalone mass facing brands by various companies, such as Glanbia, NBTY, and IOVATE are expected to drive the growth. Rising demand from body builders, elite athletes, and casual exercisers is anticipated to further propel the growth of the segment in the forthcoming years.The RTD segment is anticipated to register the fastest growth in terms of revenue from 2020 to 2027. Ready to drink protein supplements are pre-formulated drinks that are easily available. These drinks offer a high dose of protein that can consumed pre-workout, post-workout, or on the go. These products are easily absorbed by the body, they promote muscle recovery, and aid in lean muscle growth. The increasing demand for sports nutritional supplements coupled with rising demand for easy and readily available supplementation is expected to fuel the growth over the forecast period.

Application Insights of Protein Supplements Market

Sports nutrition segment held around 66.8% of the overall market share in terms of revenue in 2019. Increasing demand for sport nutritional supplements from core, strength, endurance athletes, weekend warriors, fitness enthusiasts, and professional athletes is expected to drive the demand. In addition, growing demand for sports nutritional supplementation to promote lean muscle growth, improve performance, stamina, and weight loss is projected to drive the growth.The functional food segment is projected to hold a significant market share over the forecast period. The increasing efforts to lead a healthy and active lifestyle coupled with the growing understanding about the link between exercising and maintaining a balanced and nutrient rich diet is driving the demand for protein-rich functional foods and beverages.Distribution Channel InsightsOnline stores segment held around 59.5% of the overall market share in 2019. The increasing number of internet users, ease of access, 24/7 availability, and lots of options to choose from are the factors driving online sales. Moreover, discussion portals, discounts and offers on products, and implementation of various promotion strategies will fuel online sales over the forecast period.Consumers can save money while purchasing products of their choice online within their range of budget without compromising on content, brand, and quality. Trust of consumers plays a crucial role in determining demand for a specific product, wherein the customer orders are largely reckoned through websites such as amazon, Walmart, and eBay, wherein these e-commerce focus on having a brand follow ups on regular basis.Direct to Customer (DTC) held a significant revenue share in 2019. DTC channel involves direct marketing aimed at the end consumers, companies are developing user friendly and specialized websites to market their products without the need for any third-party distribution. Major companies including Glanbia, Quest Nutrition, IOVATE, Amway, and NBTY and investing in direct to consumer channels to expand their consumer base and to extend their reach to other regions. Major retailers in U.S., including Walmart, are moving into this industry and are investing in private label varieties to promote the sale of products.Retail sale is expected to witness slower growth over the forecast period owing to strong competition from other distribution channels, such as online stores and DTC channels.Source InsightsAnimal-based segment held around 67.9% of the overall market share in terms of revenue in 2019. It consists of meat and dairy proteins including whey, casein, egg, beef, poultry, and fish. Animal based products are complete sources owing to the presence of all the essential amino acids. Milk and egg proteins are the most consumed animal based products. In addition, the presence of various nutrients including vitamin B12, vitamin D, docosahexaenoic acid (DHA), heme-iron, and zinc makes animal-based products the preferred source. Hence, the segment is anticipated to drive growth of the overall market during the forecast period.

Plant-based product segment is anticipated to witness the fastest growth over the forecast period, owing to the growing popularity among vegans, vegetarians, and people allergic to dairy and egg proteins. Plant-based products consists of proteins derived from various sources, such as soy, peas, hemp, wheat, rice, quinoa, canola, cranberry, pumpkin, potato, flax and oat. Among these sources, soy and pea were some of the dominant segments. However, plant based products are not considered to be complete sources, owing to the lack of one or more essential amino acids. So various plant based products are often blended together to account for all the essential nutrients.

Regional Insights of Protein Supplements Market

North America emerged as the largest regional market in 2019 with a share of 50.3% in terms of revenue and is expected to retain its pole position throughout the forecast period. Led by countries, such as U.S. and Canada, the regional market has been witnessing a surge in demand for sports nutritional supplements. From a raw material sourcing standpoint, key players operating in the region have been benefiting from an abundant supply of raw materials, thereby facilitating large scale production across the region.Asia Pacific is expected to expand at the fastest CAGR of 8.6% over the forecast period. Increasing consumer focus on preventive healthcare, shifting consumption patterns, westernization of diet, and increasing cost of public health care systems are some of the factors contributing to the regional market growth.In addition, factors such as the rising middle-class population and penetration of organized retail are anticipated fuel the demand for protein supplements in the forthcoming years. However, in Australia, the Therapeutic Goods Administration has proposed reclassification of the supplements as a therapeutic good or medicine from 2020. This development is expected to hamper the current growth in the country, which in turn expected to negatively impact the regional market growth.

Market Share Insights of Protein Supplements Market

The market is exceptionally aggressive with organizations undertaking activities including regular mergers, acquisitions, and capital extensions. Established players are concentrating on expanding their overall market share alongside productivity through technological innovation. Numerous global and regional players are currently operating in the market. Key protein supplement manufacturers are implementing various growth strategies to keep up with the rising demand for sports nutritional supplements from various consumers including athletes, fitness enthusiasts, and everyday people seeking active and healthier lifestyles.In October 2018, Glanbia plc acquired SlimFast one of the leading weight management and health and wellness brand manufacturing ready to mix powders, ready to drink products, and gluten free meal replacement shakes to name a few. This transition complements Glanbia Plc existing portfolio by targeting lifestyle consumers. It will also help the global consumer trends focused on convenient formats and snacking.Most major players currently hold a strong position, which is likely to pose as a barrier for new entrants. However, technological breakthrough and research expertise are likely to improve the chances of new entrants. Distribution and sales locations are other beneficial factors helping the companies enhance their overall market positioning. Prominent players have set up distribution networks for product supply in developing regions including Central and South America and Asia Pacific, owing to increasing demand from these regions.The market is dominated by major players, such as Glanbia Plc, AMCO Proteins, Quest Nutrition, NOW Foods, NBTY, MusclePharm Corp, Abbot Laboratories, Cyto Sport, IOVATE, and Transparent Labs.

Segmentations, Sub Segmentations, CAGR, & High-Level Analysis overview of Protein Supplements Market Research ReportThis report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2030. For the purpose of this study, this market research report has segmented the global protein supplements market report on the basis of source, product, distribution channels, application, and region:

Source Outlook (Revenue, USD Million, 2019 2030)

Animal-based

Whey

Casein

Egg

Fish

Others

Plant-based

Soy

Spirulina

Pumpkin Seed

Hemp

Rice

Pea

Others

Product Outlook (Revenue, USD Million, 2019 2030)

Protein Powder

Protein Bars

Ready to Drink

Others

Distribution Channel Outlook (Revenue, USD Million, 2019 2030)

Supermarkets

Online Stores

Direct to Customers (DTC)

Others

Application Outlook (Revenue, USD Million, 2019 2030)

Sports Nutrition

Functional Food

Quick Read Table of Contents of this Report @ Protein Supplements Market Size, Share, Global Market Research and Industry Forecast Report, 2027 (Includes Business Impact of COVID-19)

Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580

Read the original here:

Protein Supplements Market 2020 | Analyzing The COVID-19 Impact Followed By Restraints, Opportunities And Projected Developments - Cole of Duty